The global wearable injectors market was valued at USD 5.3 billion in 2021 and it is anticipated to grow up to USD 21.7 billion by 2031, at a CAGR of 13.3% during the forecast period.
Global Wearable Injectors Market report from Global Insight Services is the single authoritative source of intelligence on Wearable Injectors Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Drug delivery systems known as wearable injectors attach to the body and automatically administer patients’ prescribed doses at the right moment. Wearable injectors, in contrast to insulin pumps, is a one-time use devices that are comfortably worn on the body while the medication is subcutaneously injected over a pre-programmed period of seconds or hours.
Download Free Sample of Report – https://www.globalinsightservices.com/request-sample/GIS10384/
Market Trends and Drivers
A growing emphasis on the use of biologics and monoclonal antibodies (mAbs) to treat diseases such as rheumatoid arthritis, cardiovascular disease, and cancer will provide significant growth opportunities for wearable injectors, as these drugs must be administered parenterally (intravenous, subcutaneous, or intramuscular delivery). According to PhRMA (Pharmaceutical Research and Manufacturers of America), 907 biologics were in development in 2013; the number of biologic drugs in development is continuing to grow exponentially, with over 2,700 remedies in development as of mid-2017, more than tripling the 907 in development in 2013. mAb-based biotherapies account for half of the top 100 drugs and are expected to continue to dominate the pharmaceutical market.
Market Segments
By Type
- On-Body
- Off-Body
By Technology
- Spring-based
- Motor Driven
- Rotary Pump
By Application
- Diabetes
- Oncology
By End-use
- Clinics
- Hospitals
Get Customized Report as Per Your Requirement – https://www.globalinsightservices.com/request-customization/GIS10384
Key Players
- Ypsomed (Switzerland)
- Amgen (US)
- Subcuject (Denmark)
- Enable Injections (US)
- Medtronic plc (Ireland)
- Insulet Corporation (US)
- United Therapeutics Corp. (US)
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1–833–761–1700